Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0537 | 0.4145 | 0.4145 |
Echinococcus granulosus | dual specificity mitogen activated protein | 0.1237 | 1 | 1 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0537 | 0.4145 | 0.4145 |
Echinococcus multilocularis | dual specificity mitogen activated protein | 0.1237 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0066 | 0.0205 | 0.0205 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0042 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0042 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 0.1297 | 0.1297 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0537 | 0.4145 | 0.4145 |
Loa Loa (eye worm) | TAR-binding protein | 0.0066 | 0.0205 | 0.0205 |
Mycobacterium leprae | conserved hypothetical protein | 0.0042 | 0 | 0.5 |
Echinococcus multilocularis | geminin | 0.0197 | 0.1297 | 0.1297 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0066 | 0.0205 | 0.0205 |
Mycobacterium leprae | Probable lipase LipE | 0.0042 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0042 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0066 | 0.0205 | 0.0205 |
Toxoplasma gondii | ABC1 family protein | 0.0042 | 0 | 0.5 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0042 | 0 | 0.5 |
Loa Loa (eye worm) | STE/STE7/MEK7 protein kinase | 0.1237 | 1 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0042 | 0 | 0.5 |
Schistosoma mansoni | protein kinase | 0.1237 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0066 | 0.0205 | 0.0205 |
Onchocerca volvulus | 0.0042 | 0 | 0.5 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0205 | 0.0205 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0042 | 0 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0042 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0205 | 0.0205 |
Brugia malayi | RNA binding protein | 0.0066 | 0.0205 | 0.0205 |
Mycobacterium ulcerans | lipase LipD | 0.0042 | 0 | 0.5 |
Loa Loa (eye worm) | STE/STE7/MEK7 protein kinase | 0.1237 | 1 | 1 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0042 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0042 | 0 | 0.5 |
Onchocerca volvulus | 0.0042 | 0 | 0.5 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0205 | 0.0205 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0042 | 0 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0066 | 0.0205 | 0.0205 |
Mycobacterium ulcerans | beta-lactamase | 0.0042 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0267 | 0.1886 | 1 |
Trichomonas vaginalis | esterase, putative | 0.0042 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 0.1297 | 0.1297 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0205 | 0.0205 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0042 | 0 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0066 | 0.0205 | 0.0205 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0205 | 0.0205 |
Echinococcus granulosus | neuropeptide s receptor | 0.0537 | 0.4145 | 0.4145 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0042 | 0 | 0.5 |
Onchocerca volvulus | 0.0042 | 0 | 0.5 | |
Leishmania major | hypothetical protein, conserved | 0.0042 | 0 | 0.5 |
Echinococcus granulosus | geminin | 0.0197 | 0.1297 | 0.1297 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (ADMET) | > 200000 nM | Cytotoxicity against human MT4 cells assessed as growth inhibition after 4 days by MTT assay | ChEMBL. | 23316884 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.